Currently out of the existing stock ratings of Yuan Zhi, 6 are a HOLD (17.14%), 29 are a BUY (82.86%).

Yuan Zhi

Work Performance Price Targets & Ratings Chart

Analyst Yuan Zhi, currently employed at B. RILEY, carries an average stock price target met ratio of 40.42% that have a potential upside of 40.87% achieved within 52 days.

Yuan Zhi’s has documented 69 price targets and ratings displayed on 10 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on MIR, Mirion Technologies at 05-Dec-2024.

Wall Street Analyst Yuan Zhi

Analyst best performing recommendations are on FUSN (FUSION PHARMACEUTICALS ).
The best stock recommendation documented was for FUSN (FUSION PHARMACEUTICALS ) at 10/3/2023. The price target of $13 was fulfilled within 140 days with a profit of $9.78 (303.73%) receiving and performance score of 21.69.

Average potential price target upside

of $7.88 (266.49%) on FUSN (FUSION PHARMACEUTICALS ).
of $5.95 (40.1%) on AMAM (AMBRX BIOPHARMA AMERICAN DEPOSITARY SHARES).
of $1.05 (10.47%) on ISEE (IVERIC BIO).

AZTA Azenta BLFS BioLife Solutions CYRX Cryoport ISEE IVERIC bio FUSN Fusion Pharmaceuticals AMAM Ambrx Biopharma American Depositary Shares NGM NGM Biopharmaceuticals AGEN Agenus MIR Mirion Technologies TNGX Tango Therapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

David Saxon (NEEDHAM)